ROYAL BANK OF CANADA - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$534,000
-37.3%
169,772
+2.9%
0.00%
Q2 2023$852,000
-12.3%
165,055
-10.4%
0.00%
Q1 2023$971,000
+3634.6%
184,312
+1867.0%
0.00%
Q4 2022$26,000
+18.2%
9,370
+78.9%
0.00%
Q3 2022$22,000
+450.0%
5,238
+460.8%
0.00%
Q2 2022$4,000
-98.8%
934
-98.6%
0.00%
Q1 2022$339,000
-45.5%
68,543
-23.1%
0.00%
Q4 2021$622,000
-23.4%
89,171
+9.7%
0.00%
Q3 2021$812,000
-26.6%
81,277
+4.2%
0.00%
Q2 2021$1,106,000
-15.5%
77,995
-2.1%
0.00%
Q1 2021$1,309,000
-26.3%
79,702
-7.1%
0.00%
-100.0%
Q4 2020$1,775,000
+151.4%
85,782
-7.6%
0.00%
Q3 2020$706,000
-30.9%
92,794
-24.3%
0.00%
Q2 2020$1,021,000
+58.0%
122,546
-6.1%
0.00%
Q1 2020$646,000
+6.6%
130,522
-15.0%
0.00%
Q4 2019$606,000
+28.4%
153,480
-1.2%
0.00%
Q3 2019$472,000
-27.2%
155,281
+5.3%
0.00%
Q2 2019$648,000
+50.7%
147,478
+36.2%
0.00%
Q1 2019$430,000
-13.3%
108,260
-13.1%
0.00%
Q4 2018$496,000
-29.1%
124,635
+22.6%
0.00%
Q3 2018$700,000
+21.1%
101,650
+18.8%
0.00%
Q2 2018$578,000
+8.4%
85,573
+4.5%
0.00%
Q1 2018$533,000
+43.7%
81,874
-1.8%
0.00%
Q4 2017$371,000
-63.4%
83,383
-49.2%
0.00%
Q3 2017$1,014,000
-46.3%
164,061
-19.4%
0.00%
-100.0%
Q2 2017$1,887,000
+2.8%
203,558
+3.0%
0.00%0.0%
Q1 2017$1,835,000
+26.5%
197,705
+14.0%
0.00%0.0%
Q4 2016$1,451,000
+121.5%
173,374
+81.7%
0.00%
Q3 2016$655,000
+168.4%
95,415
+93.9%
0.00%
Q2 2016$244,000
+741.4%
49,210
+1534.9%
0.00%
Q1 2016$29,000
+11.5%
3,010
+8.8%
0.00%
Q4 2015$26,000
-45.8%
2,767
-19.3%
0.00%
Q3 2015$48,000
+20.0%
3,429
+80.4%
0.00%
Q2 2015$40,000
+122.2%
1,901
+341.1%
0.00%
Q1 2015$18,000
+5.9%
431
-41.7%
0.00%
Q4 2014$17,000
-69.1%
739
-79.8%
0.00%
Q3 2014$55,0003,6500.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders